alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Order entered May 15, 2013

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-13-00664-CV

IN THE INTEREST OF C.W., A CHILD

On Appeal from the 305th Judicial District Court

Dallas County, Texas

Trial Court Cause No. 11-667

ORDER

We GRANT appellant’s May 13, 2013 motion for an extension of time to file a notice of 

appeal. The notice of appeal filed in the trial court on May 10, 2013 is deemed timely for 

jurisdictional purposes.

/s/ CAROLYN WRIGHT

CHIEF JUSTICE
[Federal Register Volume 65, Number 213 (Thursday, November 2, 2000)]
[Notices]
[Page 65865]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-28098]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Child Health and Human Development; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Special Emphasis Panel Neurobiology and Genetics of 
Fragile X Syndrome.
    Date: November 14-15, 2000.
    Time: 8:00 am to 5:00 pm.
    Agenda: To review and evaluate grant applications.
    Place: Georgetown Suites, 1000 29th Street, NW., Washington, DC 
20007.
    Contact Person: Norman Chang, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health, and Human Development, National Institutes of Health, 
6100 Executive Blvd., Room 5E03, Bethesda, MD 20892, (301) 496-1485.

(Catalogue of Federal Domestic Assistance Program Nos. 93.209, 
Contraception and Infertility Loan Repayment Program; 93.864, 
Population Research for Mothers and Children; 93.929, Center for 
Medical Rehabilitation Research, National Institutes of Health, HHS)

    Dated: October 25, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-28098 Filed 11-1-00; 8:45 am]
BILLING CODE 4110-01-M
----

| a)   | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b)   | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|----------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  | November 12, 2009 | /s/ Gregory M. Bowie                                     |
|--------|-------------------|----------------------------------------------------------|
|   |              | Gregory M. Bowie                                         |
|   |              | Chief Financial Officer and Principal Accounting Officer |

----
[Federal Register Volume 65, Number 209 (Friday, October 27, 2000)]
[Notices]
[Page 64432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-27671]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration


Private Sector Participation in Overseas Trade Missions

AGENCY: International Trade Administration, Department of Commerce

ACTION: Notice

-----------------------------------------------------------------------

SUMMARY: The Department of Commerce invites U.S. companies to 
participate in the below listed overseas trade missions. For a more 
complete description of each trade mission, obtain a copy of the 
mission statement from the Project Officer indicated for each mission 
below. Recruitment and selection of private sector participants for 
these missions will be conducted according to the Statement of Policy 
Governing Department of Commerce Overseas Trade Missions dated March 3, 
1997. Textile Trade Mission to Central America and the Dominican 
Republic, El Salvador, Honduras, Dominican Republic and Guatemala, 
December 3-9, 2000. Recruitment closes on November 1, 2000.
    For further information contact: Mr. William Dawson, U.S. 
Department of Commerce. Tel: 202-482-5155, Fax: 202-482-2859, E-Mail: 
<a href="/cdn-cgi/l/email-protection#abfcc2c7c7c2cac6f4efcadcd8c4c5ebc2dfca85cfc4c885ccc4dd"><span class="__cf_email__" data-cfemail="acfbc5c0c0c5cdc1f3e8cddbdfc3c2ecc5d8cd82c8c3cf82cbc3da">[email protected]</span></a>

District Heating Mission to Russia, Moscow and St. Petersburg, May 11-
17, 2001. Recruitment closes on January 12, 2001

    For further information contact: Ms. Rachel Halpern, U.S. 
Department of Commerce. Tel: 202-482-4423, Fax: 202-482-0170, E-Mail: 
<a href="/cdn-cgi/l/email-protection#4a182b29222f2615022b263a2f38240a233e2b642e2529642d253c"><span class="__cf_email__" data-cfemail="520033313a373e0d1a333e2237203c123b26337c363d317c353d24">[email protected]</span></a>

FOR FURTHER INFORMATION CONTACT: Mr. Reginald Beckham, U.S. Department 
of Commerce. Tel: 202-482-5478, Fax: 202-482-1999.

    Dated: October 19, 2000.
Thomas H. Nisbet,
Director, Promotion Planning and Support Division, Office of Export 
Promotion Coordination.
[FR Doc. 00-27671 Filed 10-26-00; 8:45 am]
BILLING CODE 3510-DR-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 10.11
 LOAN AGREEMENT
 
 THIS LOAN AGREEMENT, is made this tenth day of January, 2011, by and among American Tony Pharmaceutical Inc (hereinafter knows as “BORROWER”) and Mr. Mingli Yao(hereinafter knows as “LENDER”). BORROWER and LENDER shall collectively be known herein as “the Parties”. In determining the rights and duties of the Parties under this Loan Agreement, the entire document must be read as a whole.
  In order to define the rights and obligations of the Borrowers and the Lender under relevant loan arrangements, the Parties hereby agree as follows:
  Article 1 Amount and Interest Rate of Loan
  1.1 Subject to the terms and conditions herein, the Lender agrees to provide the Borrowers with a line of credit up to RMB 4,000,000.
  1.2 The interest rate of the Loan hereunder is 7% per year.
  Article 2 Use and Term of Loan
  2.1
The term of the Loan hereunder shall be two(2) years, counted from the day when the Loan is provided and can be renewed every two years.
  2.2
The loan should be used for the company and its future development. Board of directors must approve it in order to use the loan.
  Article 3 Defaulting Liabilities
  3.1 The Borrowers undertake to hold the Lender harmless and indemnify the Lender against any actions, charges, claims, costs, damages, demands, expenses, liabilities, losses and proceedings which the Lender may suffer or be subject to as a result of any default by the Borrowers of its obligations hereunder.
  3.2 Notwithstanding any other provisions herein, the validity of this Article shall survive the suspension or termination of this Agreement.
  
 This agreement is made out in three originals, one for each party and one for American Tony Pharmaceutical Inc. All of them have the same force and effect.
  
  
 
 (Signature page)
  IN WITNESS WHEREOF, the Parties have caused this Loan Agreement to be executed as of the date and in the place first set forth above.
  By:
  Name: Mingli Yao
 
  American Tony Pharmaceutical Inc
  By:
  Name: Mingli Yao
  Title: President
<PAGE>   1
EXHIBIT 11.1

                                   EASCO, INC.
                   CALCULATION OF NET INCOME PER COMMON SHARE
                (NUMBERS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)


<TABLE>
<CAPTION>
                                                             THREE MONTHS ENDED                       NINE MONTHS ENDED
                                                      ---------------------------------       --------------------------------
                                                      SEPTEMBER 30,       SEPTEMBER 30,       SEPTEMBER 30,      SEPTEMBER 30,
                                                           1998                1997                1998               1997
                                                      -------------       -------------       -------------      -------------
                                                                  (UNAUDITED)                           (UNAUDITED)

<S>                                                      <C>                 <C>                 <C>                <C>    
Weighted average shares of Common Stock
     issued                                               12,480              12,419              12,469             12,416

Less:  Weighted average Treasury Stock                     2,416               2,005               2,144              2,005
            outstanding                                   ------              ------              ------             -----


Weighted average shares of Common Stock
     issued and outstanding                               10,064              10,414              10,325             10,411

Add:  Weighted average shares of Common
            Stock equivalents (stock options)                259                 322                 317                218
                                                         -------             -------             -------            -------

Weighted average shares of Common
    Stock and Common Stock equivalents
    outstanding                                           10,323              10,736              10,642             10,629
                                                         =======             =======             =======            =======

Net income                                               $ 2,045             $ 1,277             $ 7,585            $ 2,767
                                                         =======             =======             =======            =======


Basic earnings per share                                 $  0.20             $  0.12             $  0.73            $  0.27
                                                         =======             =======             =======            =======
Diluted earnings per share                               $  0.20             $  0.12             $  0.71            $  0.26
                                                         =======             =======             =======            =======
</TABLE>
[Federal Register Volume 65, Number 211 (Tuesday, October 31, 2000)]
[Notices]
[Page 65038]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-27903]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration


RTCA, Inc.; Government/Industry Certification Steering Committee

    Pursuant to section 10(a)(2) of the Federal Advisory Committee Act 
(P.L. 92-463, 5 U.S.C., Appendix 2), notice is hereby given for RTCA 
Government/Industry Certification Steering Committee meeting to be held 
November 14, 2000, from 10:00 a.m. to 2:00 p.m. The meeting will be 
held at Federal Aviation Administration (FAA), 800 Independence Avenue, 
SW., Washington, DC 20591, in the Bessie Coleman Conference Center, 
Room 2AB.
    The agenda will include: (1) Welcome and Introductory Remarks; (2) 
Report from Certification Select Committee: (a) Select Committee 
Actions from Previous Meeting; (b) Report on Working Group-1/SOIT 
Interface; (c) Report on FAA Reauthorization ACT vis-a-vis Task Force 4 
Recommendations 11 and 14; (3) Review of Select Committee Products; (d) 
Presentation of Completed Deliverables; (e) Timeline for Remaining 
Deliverables; (4) Demonstration of Proposed Certification Home Page; 
(5) Other Business; (6) Date and Location of Next Meeting; (7) Closing.
    Attendance is open to the interested public but limited to space 
availability. With the approval of the co-chairmen, members of the 
public may present oral statements at the meeting. Persons wishing to 
present statements or obtain information should contact the RTCA 
Secretariat, 1140 Connecticut Avenue, NW., Suite 1020, Washington, DC 
20036; (202) 833-9339 (phone); (202) 833-9434 (fax); or http://www.rtca.org (web site). Members of the public may present a written 
statement to the committee at any time.

    Issued in Washington, DC, on October 23, 2000.
Janice L. Peters,
Designated Official.
[FR Doc. 00-27903 Filed 10-30-00; 8:45 am]
BILLING CODE 4910-13-M
Proposed Rule: Mandatory Reporting of Greenhouse Gas Emissions 

Meeting Documentation Sierra Club, Clean Air Task Force, NRDC, Earthjustice 1/11/2011 Date Regional Staff Contact 

Information (Name, email, phone #) 

Name of Organization (Attach list of all attendees names and emails if possible) 

Summary of Discussion (e.g., applicability, 

reporting requirements, etc.)

Written ProvideDid they submit t

1/11/2011 

[All email addresses are LastName.FirstName@epa.gov] Jessica Gordon Jennifer Bohman Bill Irving Ragan Tate Mark DeFigueirdo Lisa Bacanskas Roger Fernandez Akachi Imegwu Amy Branning Cindy Anderson Deborah Ottinger Melanie Shephardson David Jacobson Lisa Hanle Lisa Grogan-McCullogh Pamela Franklin Barbora Master Katherine Sibold

Sierra Club: Craig Segall (Craig.Segall@sierraclub.org) 

Danielle Gagne Clean Air Task Force: Helen Silver NRDC: George Peridas Meleah Geertsma Earthjustice: Tim Ballo Emma Cheuse 

CBI rules, deferral, and Call for Information CCS rule, especially the R&D exemption Oil & Gas rule, especially the offshore reporting system

No
PENBECK, INC. d/b/a 

NEWBERRY'S BACKYARD 

BAR-B-Q and ANGELA 

SALISBURY,

Appellants,

v.

ROCCO T. VOGLIO, an 

individual, BEV'S BURGER 

CAFE, a Florida corporation and 

BEVERLY MILLER, an 

individual,

Appellees.

IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO 

FILE MOTION FOR REHEARING AND 

DISPOSITION THEREOF IF FILED

CASE NO. 1D14-3159

_____________________________/

Opinion filed February 20, 2015.

An appeal from the Circuit Court for Alachua County.

Toby S. Monaco, Judge.

Ralf R. Rodriguez and Monique S. Cardenas of Peckar & Abramson, Miami, for 

Appellants.

Stuart Scott Walker and Norman S. Bledsoe of Folds & Walker, LLC, Gainesville, 

for Appellees.

PER CURIAM.

AFFIRMED.

WOLF, MAKAR, and OSTERHAUS, JJ., CONCUR.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                           6,290
<SECURITIES>                                         0
<RECEIVABLES>                                  188,739
<ALLOWANCES>                                     3,032
<INVENTORY>                                    200,154
<CURRENT-ASSETS>                               402,693
<PP&E>                                          65,363
<DEPRECIATION>                                  28,224
<TOTAL-ASSETS>                                 458,999
<CURRENT-LIABILITIES>                          175,481
<BONDS>                                         95,027
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           167
<OTHER-SE>                                     185,508
<TOTAL-LIABILITY-AND-EQUITY>                   458,999
<SALES>                                        229,088
<TOTAL-REVENUES>                               229,088
<CGS>                                          209,089
<TOTAL-COSTS>                                  218,412
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 593
<INCOME-PRETAX>                                 10,083
<INCOME-TAX>                                     3,933
<INCOME-CONTINUING>                              6,150
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,150
<EPS-BASIC>                                        .37
<EPS-DILUTED>                                      .35


</TABLE>
I 

113TH CONGRESS 

1ST SESSION H. R. 3466 

To amend the Federal Election Campaign Act of 1971 to apply the prohibition 

against the conversion of contributions to personal use to contributions 

accepted by political committees. 

IN THE HOUSE OF REPRESENTATIVES 

NOVEMBER 13, 2013 

Mr. JONES (for himself, Mr. PRICE of North Carolina, and Mr. SCOTT of Virginia) introduced the following bill; which was referred to the Committee 

on House Administration 

A BILL 

To amend the Federal Election Campaign Act of 1971 to 

apply the prohibition against the conversion of contributions to personal use to contributions accepted by political committees. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘No Political Funds 

5 for Personal Use Act’’. 

mstockstill on DSK4VPTVN1PROD with BILLS

2 

•HR 3466 IH

1 SEC. 2. APPLICATION OF PROHIBITION AGAINST CONVER2 SION OF CONTRIBUTIONS TO PERSONAL USE 

3 TO CONTRIBUTIONS ACCEPTED BY POLIT4 ICAL COMMITTEES. 

5 (a) PROHIBITING CONVERSION TO PERSONAL

6 USE.—Section 313(b) of the Federal Election Campaign 

7 Act of 1971 (2 U.S.C. 439a(b)) is amended— 

8 (1) in paragraph (1), by inserting ‘‘or a receipt 

9 of any other political committee’’ after ‘‘subsection 

10 (a)’’; 

11 (2) in paragraph (2), by striking ‘‘contribution 

12 or donation’’ and inserting ‘‘contribution, donation, 

13 or receipt’’; and 

14 (3) in paragraph (2), by striking ‘‘the can15 didate’s election campaign or individual’s duties as a 

16 holder of Federal office,’’ and inserting the fol17 lowing: ‘‘the candidate’s election campaign, the indi18 vidual’s duties as a holder of Federal office, or the 

19 political committee’s political activities (as the case 

20 may be),’’. 

21 (b) EFFECTIVE DATE.—The amendments made by 

22 this section shall apply with respect to contributions or 

23 donations accepted on or after the date of the enactment 

24 of this Act. 

Æ 

mstockstill on DSK4VPTVN1PROD with BILLS
EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Berthel Growth & Income Trust I (the
"Company") on Form 10-Q for the period ending June 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas
J. Berthel, Chief Executive Officer of Berthel Fisher & Company Planning, Inc.,
the Trust Advisor of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1) The Company's Report fully complies with the requirements of
         Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.


August 12, 2008                             /s/  Thomas J. Berthel
                                            -----------------------------------
                                                 Thomas J. Berthel
                                                 President and
                                                 Chief Executive Officer
                                                 Berthel Fisher & Company
                                                 Planning, Inc.
                                                 Trust Advisor
                                                 Berthel Growth & Income Trust I
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Balance Sheet at December 31, 1998 and the Statement of Operations for the 
year ended December 31, 1998 and is qualified in its entirety by 
reference to such financial statements.
</LEGEND>
              
<S>                                    <C>
<PERIOD-TYPE>                          YEAR
<FISCAL-YEAR-END>                      DEC-31-1998
<PERIOD-END>                           DEC-31-1998
<CASH>                                           0
<SECURITIES>                                     0
<RECEIVABLES>                                    0
<ALLOWANCES>                                     0
<INVENTORY>                                      0
<CURRENT-ASSETS>                                 0
<PP&E>                                           0
<DEPRECIATION>                                   0
<TOTAL-ASSETS>                                  45
<CURRENT-LIABILITIES>                            0
<BONDS>                                          0
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<COMMON>                                        97
<OTHER-SE>                                       0
<TOTAL-LIABILITY-AND-EQUITY>                    45
<SALES>                                          0
<TOTAL-REVENUES>                                 0
<CGS>                                            0
<TOTAL-COSTS>                                    0
<OTHER-EXPENSES>                                21
<LOSS-PROVISION>                                 0 
<INTEREST-EXPENSE>                               0
<INCOME-PRETAX>                               (21)
<INCOME-TAX>                                     0
<INCOME-CONTINUING>                              0
<DISCONTINUED>                                   0
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                  (21)
<EPS-PRIMARY>                                    0
<EPS-DILUTED>                                    0

        

</TABLE>
**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTEREDPUBLIC ACCOUNTING FIRM**

Weconsent to the incorporation by reference in the Registration Statement on FormS-3 (No.’s. 333-129028, 333-131518, and 333-138720) of Metabasis Therepeutics,Inc. and in the related Prospectus and in the Registration Statement on FormS-8 (No.’s 333-116545, 333-125322, and 333-133096) of our reports dated March5, 2007, with respect to the financial statements of Metabasis Therapeutics,Inc., Metabasis Thereapeutics, Inc. management’s assessment of theeffectiveness of internal control over financial reporting, and theeffectiveness of internal control over financial reporting of MetabasisTherapeutic, Inc., included in the Annual Report (Form 10-K) for the year endedDecember 31, 2006.

/s/ Ernst & Young LLP

SanDiego, CaliforniaMarch 5, 2007

 

----